Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1

National Institute on Drug Abuse (NIDA)24 enrolled

Overview

The purpose of this study is to assess the potential interactions between iv cocaine and GBR 12909.

This is a single dose with escalation, double-blind, placebo-controlled inpatient study in which 24 cocaine experienced volunteers that meet protocol eligibility criteria during a 30 day screen period will be randomized into three dose groups.

Study Type

INTERVENTIONAL

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Cocaine-Related Disorders

Interventions

GBR 12909DRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Must understand study procedures and provide written informed consent * For additional inclusion criteria information, please contact study site for more information. Exclusion Criteria: * Please contact study site for more information.

Locations (1)

Uniformed Services University of Health Science

Bethesda, Maryland, United States

Outcomes

Primary Outcomes

Pharmacokinetic parameter comparison

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.